TY - JOUR
T1 - Eco-friendly synthesis of silver nanoparticles by Bacillus subtilis and their antibacterial activity
AU - Alsamhary, Khawla Ibrahim
N1 - Publisher Copyright:
© 2020 The Author(s)
PY - 2020/8
Y1 - 2020/8
N2 - Bacillus subtilis was used for biogenic of silver nanoparticles. Characterization of the prepared silver nanoparticles was done by UV–Vis spectroscopy, Transmission Electron Microscopy (TEM), and Fourier Transform Infrared Spectroscopy (FT-IR). The particle size of the prepared nanoparticles ranges from 3 to 20 nm with spherical or roughly spherical forms. The antimicrobial efficacy of the produced nanoparticles was investigated against five strains of multidrug resistant microorganisms including: Staphylococcus aureus (MRSA), Staphylococcus epidermidis, Klebsiella. pneumoniae, Escherichia coli and Candida albicans tested as yeast. During this study, the minimum inhibitory concentrations (MICs) and the minimum lethal concentrations (MLCs) of synthesized silver nanoparticles were detected using selected strains of the genus Bacillus by a broth dilution method. The rate of MIC of the prepared silver nano-particles versus the investigated clinical isolates exhibit a massive anti-microbial efficacy; (230 µgml−1) for MRSA; 180 for Staphylococcus epidermidis, 200 for Escherichia coli and 100 µgml−1 for Candida albicans. On the other hand, the lowest anti-microbial efficacy (300 µgml−1) was appeared for Klebsiella pneumonia. The obtained results demonstrated the effectiveness of the biogenic nanoparticles and the possibility of using them as a new method in combating infectious diseases.
AB - Bacillus subtilis was used for biogenic of silver nanoparticles. Characterization of the prepared silver nanoparticles was done by UV–Vis spectroscopy, Transmission Electron Microscopy (TEM), and Fourier Transform Infrared Spectroscopy (FT-IR). The particle size of the prepared nanoparticles ranges from 3 to 20 nm with spherical or roughly spherical forms. The antimicrobial efficacy of the produced nanoparticles was investigated against five strains of multidrug resistant microorganisms including: Staphylococcus aureus (MRSA), Staphylococcus epidermidis, Klebsiella. pneumoniae, Escherichia coli and Candida albicans tested as yeast. During this study, the minimum inhibitory concentrations (MICs) and the minimum lethal concentrations (MLCs) of synthesized silver nanoparticles were detected using selected strains of the genus Bacillus by a broth dilution method. The rate of MIC of the prepared silver nano-particles versus the investigated clinical isolates exhibit a massive anti-microbial efficacy; (230 µgml−1) for MRSA; 180 for Staphylococcus epidermidis, 200 for Escherichia coli and 100 µgml−1 for Candida albicans. On the other hand, the lowest anti-microbial efficacy (300 µgml−1) was appeared for Klebsiella pneumonia. The obtained results demonstrated the effectiveness of the biogenic nanoparticles and the possibility of using them as a new method in combating infectious diseases.
KW - AgNPs
KW - Antimicrobial activity
KW - Bacillus subtilis
KW - Green biosynthesis
UR - http://www.scopus.com/inward/record.url?scp=85084458386&partnerID=8YFLogxK
U2 - 10.1016/j.sjbs.2020.04.026
DO - 10.1016/j.sjbs.2020.04.026
M3 - Article
AN - SCOPUS:85084458386
SN - 1319-562X
VL - 27
SP - 2185
EP - 2191
JO - Saudi Journal of Biological Sciences
JF - Saudi Journal of Biological Sciences
IS - 8
ER -